Cargando…

Clinical usefulness of transarterial chemoembolization response prior to liver transplantation as predictor of optimal timing for living donor liver transplantation

PURPOSE: Response to preoperative transarterial chemoembolization (TACE) has been recommended as a biological selection criterion for liver transplantation (LT). The aim of our study was to identify optimal timing of living donor liver transplantation (LDLT) after TACE based on the TACE response. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Chan Woo, Choi, Gyu-Seong, Kim, Jong Man, Kwon, Choon Hyuck David, Kim, Doo Jin, Joh, Jae-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073044/ https://www.ncbi.nlm.nih.gov/pubmed/30079328 http://dx.doi.org/10.4174/astr.2018.95.2.111

Ejemplares similares

Living donor liver transplantation prior to multiple myeloma treatment in a patient with hepatitis B-associated hepatocellular carcinoma and liver cirrhosis: a case report
por: Cho, Chan Woo, et al.
Publicado: (2018)

Comparative Peripheral Blood T Cells Analysis Between Adult Deceased Donor Liver Transplantation (DDLT) and Living Donor Liver Transplantation (LDLT)
por: Kim, Jong Man, et al.
Publicado: (2017)

Postoperative Health Status and Quality of Life After Pure Laparoscopic Donor Hepatectomy for Living Donor Liver Transplantation
por: Cho, Chan Woo, et al.
Publicado: (2022)

Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
por: Rhu, Jinsoo, et al.
Publicado: (2018)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
por: Benkö, Tamás, et al.
Publicado: (2022)

Prediction of Complete Necrosis of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Prior to Liver Transplantation
por: Kim, Sue Jin, et al.
Publicado: (2009)

Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation
por: Lee, Jisun, et al.
Publicado: (2021)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Hepatic venous territory mapping in living donor liver transplantation using right liver graft: an objective parameter for venous reconstruction
por: Yang, Jaehun, et al.
Publicado: (2023)

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation
por: Lee, Okjoo, et al.
Publicado: (2022)

Postoperative changes of liver enzymes can distinguish between biliary stricture and graft rejection after living donor liver transplantation: A longitudinal study
por: Woo, Young Sik, et al.
Publicado: (2017)

Bile Duct Reconstruction by a Young Surgeon in Living Donor Liver Transplantation Using Right Liver Graft
por: Kim, Jong Man, et al.
Publicado: (2014)

Comparison of liver regeneration in laparoscopic versus open right hemihepatectomy for adult living donor liver transplantation
por: Yang, Jaehun, et al.
Publicado: (2020)

Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot Study
por: Kim, Jong Man, et al.
Publicado: (2015)

Poor outcomes of early recurrent post-transplant bloodstream infection in living-donor liver transplant recipients
por: Kim, Si-Ho, et al.
Publicado: (2020)

Early reoperation after adult living-donor liver transplantation is associated with poor survival
por: Lim, Manuel, et al.
Publicado: (2019)

Long-term Outcome of Endoscopic Retrograde Biliary Drainage of Biliary Stricture Following Living Donor Liver Transplantation
por: Park, Jae Keun, et al.
Publicado: (2020)

Extracorporeal membrane oxygenation support for refractory septic shock in liver transplantation recipients
por: Lee, Kyo Won, et al.
Publicado: (2017)

Clinical Efficacy of Pretransplant Vaccination for Preventing Herpes Zoster After Living Donor Liver Transplantation in Recipients Age 50 Years and Older
por: Cho, Chan Woo, et al.
Publicado: (2019)

Encapsulating peritoneal sclerosis in liver transplant recipients: a report of 2 cases
por: Lee, Kyo Won, et al.
Publicado: (2017)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Pneumatosis intestinalis after adult liver transplantation
por: Kim, Jong Man, et al.
Publicado: (2011)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
por: Lee, Seohee, et al.
Publicado: (2021)

Liver Transplantation for Metabolic Liver Disease: Experience at a Living Donor Dominant Liver Transplantation Center
por: Kim, Jun Suk, et al.
Publicado: (2015)

Response to transarterial chemoembolization may serve as selection criteria for hepatocellular carcinoma liver transplantation
por: Lei, Jianyong, et al.
Publicado: (2017)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Zhang, Xia, et al.
Publicado: (2023)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Living donor liver transplantation for patients with alcoholic liver disease
por: Park, Yo-Han, et al.
Publicado: (2013)

Bacterial infection monitoring in the early period after liver transplantation
por: Lee, Ji Soo, et al.
Publicado: (2018)

Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
por: Kim, Jong Man, et al.
Publicado: (2017)

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
por: Kim, Jong Man, et al.
Publicado: (2018)

Outcome of donor biliary complications following living donor liver transplantation
por: Woo, Hyun Young, et al.
Publicado: (2018)

Conceptual changes in small-for-size graft and small-for-size syndrome in living donor liver transplantation
por: Ikegami, Toru, et al.
Publicado: (2019)

The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline
por: Miller, Charles M., et al.
Publicado: (2017)

Infections after Living Donor Liver Transplantation in Children
por: Kim, Jeong Eun, et al.
Publicado: (2010)

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
por: Kim, Jong Man, et al.
Publicado: (2016)

Intraoperative Ultrasonography as a Guidance for Dividing Bile Duct During Laparoscopic Living Donor Hepatectomy
por: Rhu, Jinsoo, et al.
Publicado: (2019)

Feasibility of laparoscopic liver resection for liver cavernous hemangioma: A single-institutional comparative study
por: Shin, Younghuen, et al.
Publicado: (2020)

The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation
por: Kim, Sang Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dj38tt1bvlte650jquqtq37mom